The Two Years Before Dialysis Decide How That Transition Goes.
A patient who reaches kidney failure with an established access, an informed modality choice and a transplant evaluation underway has a fundamentally different experience from one who arrives at dialysis through an emergency admission and a catheter.
The difference is made in the preceding months, in work that is almost entirely coordination.
The Opportunity
Slowing Progression Is Mostly Between-Visit Work
The interventions that slow chronic kidney disease are unglamorous and continuous. Blood pressure to target. Renin angiotensin blockade maintained through the transient creatinine rise that frightens patients and other prescribers into stopping it. SGLT2 inhibition where indicated. Consistent avoidance of the nephrotoxins patients pick up from every other part of the health system.
None of that happens at an appointment. It happens in the weeks between appointments, and it depends on somebody noticing when a patient has been handed an NSAID by an urgent care clinic or booked for a contrast study by a specialist who did not check their function.
Who Qualifies
Which of Your Patients Qualify
THE POPULATIONS WHERE STRUCTURED MANAGEMENT MOST AFFECTS TRAJECTORY:
CKD stages 3b through 5, not yet on dialysis:
The core population, where progression is still modifiable and transition planning has real lead time.
Diabetic kidney disease:
The largest single subgroup and the one with the most competing management priorities.
Hypertensive nephropathy or resistant hypertension with CKD:
Where home blood pressure data drives the regimen directly.
Patients with recurrent fluid overload:
Daily weight tracking supports diuretic management on the same logic that applies in heart failure.
Cardiorenal patients:
Where cardiology and nephrology pull in opposite directions and somebody needs to hold both views at once.
Patients approaching modality decisions:
The education and evaluation window, which is coordination-intensive and time-sensitive.
Transplant candidates in workup:
A multi-appointment, multi-facility process that stalls without someone tracking each step.
And who we would leave out:
Stable stage 3a CKD with no progression, no proteinuria and no second qualifying condition.
Patients on maintenance dialysis, where a separate billing construct applies and the interaction must be confirmed with your billing lead first.
Patients already enrolled in a care management program by cardiology or primary care.
Program Fit
Where Each Program Does the Work
CCM is where nephrology gets most of its value
Medication safety is the dominant theme and the one with the clearest return. Renal dosing errors are common, nephrotoxic exposures arrive from outside your practice, and contrast studies get ordered by physicians who did not check function. A coordinator reviewing every new medication against renal dosing is doing protective work.
Alongside that sits the scaffolding: anemia and mineral bone disorder monitoring, dietary counseling reinforcement, lab schedule adherence, vaccination status, and the multi-appointment logistics of transplant evaluation and access planning.
RPM contributes on two measurements
Blood pressure is the single most important modifiable factor in progression, and home readings are more reliable than office readings for titration decisions in this population.
Weight supports fluid management in patients with a history of overload, on the same logic that applies in heart failure. Beyond those two, the useful nephrology measurements are laboratory values rather than device readings, which places them outside the remote monitoring construct.
Monthly Touchpoint
What the Monthly Touchpoint Actually Covers
Nephrology monthly contact is weighted heavily toward medication safety:
New medication review.
Everything the patient has started since the last contact, from any source, checked for appropriateness at their current level of function.
Nephrotoxin surveillance.
NSAIDs from urgent care or the pharmacy shelf, contrast studies booked elsewhere, herbal supplements. Asked about directly, because patients do not think of these as medications.
Blood pressure trend and titration support.
Including reinforcement when a transient creatinine rise after starting or increasing RAAS blockade prompts a patient or another prescriber to stop it.
Fluid and dietary adherence.
Sodium, potassium, phosphorus and protein, revisited concretely. These instructions are complex, frequently misunderstood, and rarely re-explained after the first counseling session.
Lab schedule adherence.
CKD management depends on regular monitoring, and missed labs are among the most common reasons management drifts.
Transition and evaluation tracking.
Access planning, modality education and transplant workup steps, each with an owner and a next date rather than a general intention.
Clinical value
What Changes
The intervention that recurs most often is small and entirely preventive. A coordinator learns during a routine call that a patient was given an anti-inflammatory at an urgent care visit for back pain. It is caught within days rather than at the next quarterly appointment, and the decline in function does not happen.
The larger change is in transition quality. Patients contacted monthly through the eighteen months before kidney failure arrive at that point with an informed modality choice made, access placed and a transplant evaluation underway. That is a different clinical event from the alternative, and the difference is made almost entirely of coordination.
Confirm the dialysis interaction before you enroll anyone. Monthly care for patients on maintenance dialysis is billed under its own construct, and how that interacts with care management for the same patient has to be settled with your billing lead first. Our recommendation is to build the program around the pre-dialysis population, where the clinical case is strongest and the billing question does not arise.
Questions Nephrology Practices Ask
Most of our patients also see cardiology. Who runs the program?
Whoever is managing the dominant problem. For a cardiorenal patient where kidney function is driving decisions, nephrology is usually the right home. Where heart failure dominates, cardiology usually is. What matters is that only one practice bills and that both know which one it is. We settle this before enrollment rather than after a denial.
Can coordinators interpret lab results?
No. They track whether labs were drawn, flag results outside the parameters you define, and make sure the patient attends the follow-up. Interpretation and any resulting decision stay with your physicians.
Does this help with transplant referral rates?
It helps with completion more than referral. Transplant evaluation stalls in the middle far more often than at the start. A test not scheduled, a consultation not attended, a document not returned. Someone tracking each step to completion addresses the actual failure point.
Our patients have complex dietary restrictions they do not follow. Does a monthly call change that?
Partially, and we would not overclaim. Renal diets are difficult and adherence is imperfect regardless. What monthly contact reliably improves is comprehension, and a large share of apparent non-adherence turns out to be patients following instructions they misunderstood, which is a fixable problem.
Start With Your Stage 4 Pre-Dialysis Patients
The clinical case is strongest, the billing questions are simplest, and the transition planning window is where coordination produces the most visible difference.